Prescription-strength topical corticosteroids available over the counter: Cross-sectional study of 80 stores in 13 United States cities - 09/01/20

Rebecca S. Kimyon, BS ^{a, b, ⁎} , Jamie P. Schlarbaum, BS ^{a, b}, Yujie Linda Liou, DO ^a, Brandon L. Adler, MD ^c, Alyssa Breneman, BA ^d, Jeanette R. Comstock, MD ^e, Chelsea Handfield, BA ^f, Dawson Kimyon, HSDG ^g, Hannah Kopelman, DO ^h, Ross Kopelman, DO ⁱ, Vidhi Patel, BS ^j, Jodie Raffi, BA ^k, Fernanda Salgado, MD ^l, Sara A. Hylwa, MD ^a, Erin M. Warshaw, MD, MS ^{a, m}

^a Park Nicollet Contact Dermatitis Clinic, Minneapolis, Minnesota 

^b University of Minnesota Medical School, Minneapolis, Minnesota 

^c Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California 

^d Vagelos College of Physicians and Surgeons, Columbia University, New York, New York 

^e School of Medicine & Public Health, University of Wisconsin, Madison, Wisconsin 

^f School of Medicine, Duke University, Durham, North Carolina 

^g University of Minnesota, Minneapolis, Minnesota 

^h Department of Dermatology, Boston University Medical Center, Boston, Massachusetts 

ⁱ St. John's Episcopal Hospital, Far Rockaway, New York 

^j Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 

^k School of Medicine, University of California-Irvine, Irvine, California 

^l Department of Dermatology, Weill Cornell Medicine, New York, New York 

^m Department of Dermatology, University of Minnesota, Minneapolis, MN 

^∗Correspondence to: Rebecca S. Kimyon, BS, Park Nicollet Contact Dermatitis Clinic, 7550 34th Ave S, Ste #101, Minneapolis, MN 55450Park Nicollet Contact Dermatitis Clinic7550 34th Ave S, Ste #101MinneapolisMN55450